Form 4 for IRON Disc Medicine, Inc.
Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-03 · accession 0000950170-25-019085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-12 | 2025-02-10 | IRON | Savage William Jacob | Chief Medical Off | A - Grant | $0.00 | +24.0K | 70.1K | +52% | $0 |
| DM | 2025-02-12 | 2025-02-03 | IRON | Savage William Jacob | Chief Medical Off | M - OptEx | $2.65 | +5,731 | 44.6K | +15% | +$15.2K |
| DM | 2025-02-12 | 2025-02-03 | IRON | Savage William Jacob | Chief Medical Off | M - OptEx | $0.00 | -5,731 | 0 | -100% | $0 |
| D | 2025-02-12 | 2025-02-10 | IRON | Savage William Jacob | Chief Medical Off | A - Grant | $0.00 | +36.0K | 36.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-10 | A | A | 24,000 | $0.00 | 70,136 | D | — | — | (F1) Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2026, subject to the Reporting Person's continued service on each such vesting date. |
| 2 | Common | Common Stock | 2025-02-03 | M | A | 1,498 | $2.65 | 46,136 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-03 | M | A | 4,233 | $2.65 | 44,638 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | M | D | 4,233 | $0.00 | 0 | D | $2.65 · — to 2030-08-10 | 4,233 Common Stock | (F2) 25% of the shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | M | D | 1,498 | $0.00 | 0 | D | $2.65 · — to 2030-10-22 | 1,498 Common Stock | (F3) 2,140 shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 38 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-02-10 | A | A | 36,000 | $0.00 | 36,000 | D | $54.71 · — to 2035-02-09 | 36,000 Common Stock | (F4) The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2025, subject to the Reporting Person's continuted service on each such vesting date. |